PGNY
Progyny, Inc.Company Information
- Company Name
- Progyny, Inc.
- CIK
- CIK0001551306
- Category
- Large accelerated filer
- Ticker: Exchange
- PGNY: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8090
- SIC Description
- Services-Misc Health & Allied Services, NEC
- Ticker
- PGNY
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-11-13
- Last sale
- 2026-09-23
- Shares purchased (TTM)
- 79,500
- Shares sold (TTM)
- 85,921
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 77,440,877
- Shares outstanding
- 78,165,235
- Ownership
- 99.07%
Earnings Market Reaction
- Filing date
- 2026-08-07
- Price on filing date
- —
- 1-month reaction
- -7.47%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 153 | 132 | 112 | 134 | 133 | 109 | 162 | 91 | 95 | 115 | 97 | 158 | ||||||
| Available For Sale Securities Debt Securities Current | 84 | 94 | 198 | 211 | 173 | 147 | 66 | 144 | 167 | 257 | 274 | 177 | ||||||
| Accounts Receivable Net Current | 257 | 264 | 220 | 253 | 272 | 300 | 235 | 281 | 294 | 297 | 242 | 269 | ||||||
| Prepaid Expense And Other Assets Current | 19 | 13 | 21 | 24 | 17 | 12 | 9 | 30 | 26 | 12 | 27 | 7 | ||||||
| Assets Current | 513 | 502 | 552 | 622 | 594 | 568 | 473 | 546 | 582 | 682 | 640 | 611 | ||||||
| Property Plant And Equipment Net | 42 | 36 | 30 | 25 | 20 | 16 | 12 | 12 | 11 | 10 | 10 | 10 | ||||||
| Operating Lease Right Of Use Asset | 24 | 24 | 25 | 26 | 26 | 27 | 17 | 17 | 18 | 17 | 18 | 18 | ||||||
| Goodwill | 20 | 20 | 20 | 20 | 20 | 20 | 16 | 16 | 16 | 12 | 12 | 12 | ||||||
| Finite Lived Intangible Assets Net | 6 | 6 | 6 | 6 | 7 | 7 | 1 | 1 | 1 | - | 0 | 0 | ||||||
| Deferred Income Tax Assets Net | 93 | 93 | 93 | 85 | 85 | 85 | 85 | 64 | 68 | 70 | 73 | 72 | ||||||
| Other Assets Noncurrent | 19 | 18 | 17 | 12 | 9 | 9 | 3 | 3 | 3 | 3 | 3 | 4 | ||||||
| Assets | 716 | 698 | 742 | 795 | 761 | 730 | 607 | 660 | 699 | 794 | 757 | 727 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 152 | 158 | 124 | 123 | 141 | 146 | 95 | 130 | 152 | 130 | 125 | 132 | ||||||
| Liabilities Current | 240 | 236 | 202 | 210 | 220 | 237 | 169 | 208 | 225 | 206 | 186 | 193 | ||||||
| Operating Lease Liability Noncurrent | 22 | 23 | 24 | 25 | 26 | 26 | 16 | 17 | 17 | 17 | 17 | 18 | ||||||
| Liabilities | 263 | 259 | 226 | 235 | 246 | 263 | 185 | 225 | 242 | 223 | 203 | 211 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 735 | 718 | 701 | 673 | 642 | 612 | 582 | 552 | 520 | 489 | 462 | 438 | ||||||
| Treasury Stock Common Value | -538 | -506 | -388 | -304 | -304 | -304 | -304 | -251 | -189 | -27 | -1 | -1 | ||||||
| Retained Earnings Accumulated Deficit | 255 | 227 | 203 | 190 | 176 | 159 | 144 | 134 | 123 | 107 | 90 | 77 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 3 | 2 | ||||||
| Stockholders Equity | 453 | 439 | 516 | 560 | 515 | 467 | 422 | 435 | 456 | 572 | 553 | 515 | ||||||
| Liabilities And Stockholders Equity | 716 | 698 | 742 | 795 | 761 | 730 | 607 | 660 | 699 | 794 | 757 | 727 | ||||||
Accounts Receivable Net Current | ||||||||||||||||||
| Allowance For Doubtful Accounts Receivable | 55 | 56 | 56 | 55 | - | - | 56 | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | ||||||
| Allowance For Doubtful Accounts Receivable Current | - | - | - | - | - | - | 56 | 56 | 54 | 50 | 47 | 43 | ||||||
Common Stock Number Of Shares Par Value And Other Disclosures | ||||||||||||||||||
| Common Stock Shares Issued | 100 | 99 | 99 | 99 | 98 | 98 | 98 | 97 | 97 | 97 | 96 | 96 | ||||||
| Shares Outstanding | 77 | 78 | 83 | 86 | 86 | 86 | 85 | 88 | 91 | 96 | 96 | 96 | ||||||
Treasury Stock Number Of Shares And Restriction Disclosures | ||||||||||||||||||
| Treasury Stock Common Shares | 23 | 22 | 16 | 13 | 13 | 13 | 13 | 10 | 7 | 1 | 1 | 1 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialProgyny, Inc. (PGNY) — SEC Financial Statements & Analysis
Progyny, Inc. (PGNY) is a services-misc health & allied services, nec company, incorporated in DE. Progyny, Inc. trades on Nasdaq as: PGNY. Progyny, Inc. (PGNY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07. Based on that filing, Progyny, Inc. carries a market cap of $2.25B, a P/E ratio of 28.66x, a P/B ratio of 4.97x, a P/S ratio of 1.72x, an enterprise value of $2.10B, and an EV/EBITDA multiple of 17.81x. On profitability, it posts a gross margin of 24.57%, an operating margin of 8.55%, a net margin of 6.00%, a Return on Equity (ROE) of 16.24%, a Return on Assets (ROA) of 10.65%, and a Return on Invested Capital (ROIC) of 20.24%. Per share, it reports EPS of $1.01, diluted EPS of $0.96, free cash flow per share of $2.28, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 5.54% year-over-year, net income growth of 48.02% year-over-year, and EPS growth of 62.41% year-over-year. On the balance sheet, it maintains a current ratio of 2.14x, a quick ratio of 2.06x, working capital of $272.93M, a debt-to-equity ratio of 0.58x, a debt ratio of 0.37, an interest coverage ratio of 89.59x, free cash flow of $178.38M (TTM), and net debt of $-154.60M. Figures sourced from SEC EDGAR.
- Market Cap
- $2.25B
- P/E TTM
- 28.66x
- EPS TTM
- $1.01
- P/B TTM
- 4.97x
- ROE TTM
- 16.24%
- ROA TTM
- 10.65%
- Debt To Equity
- 0.58x
- Free Cash Flow TTM
- $178.38M
- Net Revenue TTM Growth 1Y
- 5.54%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Progyny, Inc. in?
Progyny, Inc. (PGNY) operates in the Services-Misc Health & Allied Services, NEC industry.
What exchange does PGNY trade on?
Progyny, Inc. (PGNY) trades on the Nasdaq.
Where is Progyny, Inc. incorporated?
Progyny, Inc. is incorporated in DE.
When was Progyny, Inc. (PGNY)'s most recent SEC filing?
Progyny, Inc. (PGNY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07.
What is PGNY's market cap?
Progyny, Inc. (PGNY) has a market capitalization of $2.25B as of 2026-06-30.
What is PGNY's P/E ratio?
Progyny, Inc. (PGNY)'s trailing twelve month P/E ratio is 28.66x as of 2026-06-30.
What is PGNY's EPS (earnings per share)?
Progyny, Inc. (PGNY)'s trailing twelve month EPS is $1.01 as of 2026-06-30.
What is PGNY's ROE (return on equity)?
Progyny, Inc. (PGNY)'s trailing twelve month Return on Equity (ROE) is 16.24% as of 2026-06-30.
What is PGNY's ROA (return on assets)?
Progyny, Inc. (PGNY)'s trailing twelve month Return on Assets (ROA) is 10.65% as of 2026-06-30.
What is PGNY's ROIC (return on invested capital)?
Progyny, Inc. (PGNY)'s trailing twelve month Return on Invested Capital (ROIC) is 20.24% as of 2026-06-30.
What is PGNY's EV/EBITDA?
Progyny, Inc. (PGNY)'s trailing twelve month EV/EBITDA is 17.81x as of 2026-06-30.